Mounjaro 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F3TWJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,540
Award facts
- Contract value 100% obligated
- $23,539.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $23,539.63 delivery order to AmerisourceBergen Drug Corp on January 16, 2026, for the supply of Mounjaro 7.5 mg/0.5 mL pen injections with an ultimate completion date of January 20, 2026. This firm fixed-price contract, which was not set aside for small businesses or other designated groups, is structured as a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control, consistent with AmerisourceBergen's broader portfolio of pharmaceutical products supplied to federal military and healthcare systems.
This delivery order represents a task order execution under AmerisourceBergen's comprehensive $999,999,999 IDC with DLA Troop Support Medical, which extends through December 2026 and serves as a global pharmaceutical support vehicle for military healthcare programs. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds this prime contract and maintains significant pharmaceutical distribution relationships across multiple federal agencies including the Defense Health Agency and Department of Veterans Affairs. The competitively awarded structure and firm fixed-price model reflect AmerisourceBergen's established capability to meet federal procurement requirements for critical pharmaceutical commodities supporting military treatment facilities and veteran healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DR26F3TWJ?
SPE2DR26F3TWJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26F3TWJ worth?
The government has obligated $23,540 on SPE2DR26F3TWJ.
Is contract SPE2DR26F3TWJ an order under another contract?
Yes. SPE2DR26F3TWJ is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3TWJ competed?
The extent of competition for SPE2DR26F3TWJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award